Biotech Analysts hold a conference call with management on October 1 at 11 am hosted by JPMorgan.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYMR:
- Kymera Therapeutics price target raised to $63 from $53 at Oppenheimer
- Kymera Therapeutics price target raised to $68 from $53 at Truist
- Kymera Therapeutics price target raised to $70 from $60 at H.C. Wainwright
- Kymera Therapeutics: Promising Developments and Buy Rating Amidst Significant Clinical Advancements
- Kymera Therapeutics to present on KT-621 at EADV Congress